Compile Data Set for Download or QSAR
Report error Found 450 Enz. Inhib. hit(s) with Target = 'Mitogen-activated protein kinase 12'
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human P38g using myelin basic protein as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM13533(1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-m...)
Affinity DataKd:  2.90nMAssay Description:Binding constant for p38-gamma kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342101(US9771353, Example 1 | 3-((4-((4-(3-(3-(tert-Butyl...)
Affinity DataIC50: 5nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142598(US8933228, Ref 2 | US9249125, Reference Compound |...)
Affinity DataKd:  5nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142598(US8933228, Ref 2 | US9249125, Reference Compound |...)
Affinity DataKd:  5nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142598(US8933228, Ref 2 | US9249125, Reference Compound |...)
Affinity DataKd:  5nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342110(US9771353, Example 10 | 3-Ethynyl-5-((4-((4-(3-(3-...)
Affinity DataIC50: 9nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50605761(CHEMBL5197888)
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant human full length His-tagged p38gamma expressed in baculovirus expression system preincubated for 2 hrs followed by ATP add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342102(US9771353, Example 2 | 1-(3-(tert-Butyl)-1-methyl-...)
Affinity DataIC50: 10nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334348(1-(4-((2-((3-(2,5,8,11,14,17,20-Heptaoxadocosan-22...)
Affinity DataIC50: 11nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342107(US9771353, Example 7 | 3-((4-((4-(3-(3-(tert-Butyl...)
Affinity DataIC50: 11nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342111(US9771353, Example 11 | 3-Ethynyl-5-((4-((4-(3-(3-...)
Affinity DataIC50: 13nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM13533(1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-m...)
Affinity DataKd:  14nMAssay Description:Average Binding Constant for p38-gamma; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50605756(CHEMBL5184542)
Affinity DataIC50: 16nMAssay Description:Inhibition of recombinant human full length His-tagged p38gamma expressed in baculovirus expression system preincubated for 2 hrs followed by ATP add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM13533(1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-m...)
Affinity DataKd:  19nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2011
Entry Details
PCBioAssay
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM13533(1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-m...)
Affinity DataKd:  19nMAssay Description:Binding constant for full-length p38-gammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142613(US8933228, 29)
Affinity DataIC50: 19nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342108(US9771353, Example 8 | 3-((4-((4-(3-(3-(tert-Butyl...)
Affinity DataIC50: 20nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142622(US8933228, 13)
Affinity DataIC50: 23nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142626(US8933228, 18)
Affinity DataIC50: 24nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142601(US8933228, 3)
Affinity DataIC50: 24nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334325(1-(3-Isopropyl-1-(P-tolyl)-1H-pyrazol-5-yl)-3-(4-(...)
Affinity DataIC50: 26nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334336(1-(4-((2-((3-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)...)
Affinity DataIC50: 26nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334319(3-(4-((4-(3-(3-(tert-Butyl)-1-(6-methoxypyridin-3-...)
Affinity DataIC50: 28nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM31085(cid_11409972 | 1-[4-[(4-ethylpiperazin-1-yl)methyl...)
Affinity DataKd:  29nMAssay Description:Binding constant for full-length p38-gammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM31085(cid_11409972 | 1-[4-[(4-ethylpiperazin-1-yl)methyl...)
Affinity DataKd:  29nMAssay Description:Binding constant for p38-gamma kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142610(US8933228, 26)
Affinity DataIC50: 29nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334345(1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...)
Affinity DataIC50: 30nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM13533(1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-m...)
Affinity DataIC50: 30nMAssay Description:Inhibition of P38gammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334346(1-(4-((2-((3-(2,5,8,11,14-Pentaoxahexadecan-16-ylo...)
Affinity DataIC50: 32nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142627(US8933228, 19)
Affinity DataIC50: 35nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM342103(US9771353, Example 3 | 1-(3-(tert-Butyl)-1-methyl-...)
Affinity DataIC50: 36nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142614(US8933228, 30)
Affinity DataIC50: 39nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142597(US8933228, Ref 1)
Affinity DataIC50: 40nMAssay Description:Inhibition of human recombinant p38 gamma assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2017
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142629(US8933228, 21)
Affinity DataIC50: 41nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  42nMAssay Description:Binding constant for full-length p38-gammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  42nMAssay Description:Binding constant for p38-gamma kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM31096(CHEMBL290084 | Staurosporine | cid_451705 | US2024...)
Affinity DataKd:  42nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2011
Entry Details
PCBioAssay
TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM161376(US9108950, 1 | US9724347, Example 1 | US10238658, ...)
Affinity DataKd:  43nMAssay Description:The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2016
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142603(US8933228, 5)
Affinity DataIC50: 43nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM161376(US9108950, 1 | US9724347, Example 1 | US10238658, ...)
Affinity DataKd:  43nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM161376(US9108950, 1 | US9724347, Example 1 | US10238658, ...)
Affinity DataKd:  43nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashion to that descr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM161376(US9108950, 1 | US9724347, Example 1 | US10238658, ...)
Affinity DataKd:  43nMAssay Description:p38 MAPKγ: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), were evaluated in a similar fashi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142628(US8933228, 20)
Affinity DataIC50: 44nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142624(US8933228, 16)
Affinity DataIC50: 45nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142619(US8933228, 10)
Affinity DataIC50: 45nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142615(US8933228, 31)
Affinity DataIC50: 47nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334327(3-(4-((4-(3-(3-Isopropyl-1-(p-tolyl)-1H-pyrazol-5-...)
Affinity DataIC50: 50nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM142609(US8933228, 22 | US8933228, 25)
Affinity DataIC50: 50nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
US Patent

TargetMitogen-activated protein kinase 12(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM334367(1-(4-((2-((3-(2,5,8,11,14,17,20-Heptaoxadocosan-22...)
Affinity DataIC50: 53nMAssay Description:The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2019
Entry Details
US Patent

Displayed 1 to 50 (of 450 total ) | Next | Last >>
Jump to: